116 related articles for article (PubMed ID: 12437646)
41. [Haematological malignancies: incidence in Basse-Normandie, France, for 1997-2004].
Troussard X; Duchenet V; Cornet E; Mouchel D; Malet M; Collignon A
Rev Epidemiol Sante Publique; 2009 Jun; 57(3):151-8. PubMed ID: 19375876
[TBL] [Abstract][Full Text] [Related]
42. Estimation of completeness of case ascertainment of Austrian cancer incidence data using the flow method.
Hackl M; Waldhoer T
Eur J Public Health; 2013 Oct; 23(5):889-93. PubMed ID: 23002230
[TBL] [Abstract][Full Text] [Related]
43. The incidence and survival of Waldenström's Macroglobulinaemia in South East England.
Phekoo KJ; Jack RH; Davies E; Møller H; Schey SA;
Leuk Res; 2008 Jan; 32(1):55-9. PubMed ID: 17416416
[TBL] [Abstract][Full Text] [Related]
44. [Organizational models for the hematology areas of the district hospitals of Catalonia].
Salinas R; Asensio A; Tuset E; Abella E; Bosch A; Las Heras G; Escoda L; Farré V; García M; García M; Jiménez C; Kian C; Martín E; Oriol A; Orriols J; Panadés M; Pero A; Prat M; Ramón O; Revilla E; Segalés JM; Vallés A
Sangre (Barc); 1996 Jun; 41(3):211-20. PubMed ID: 8755209
[TBL] [Abstract][Full Text] [Related]
45. The Impact of Hospital Discharge Linkage on Case Ascertainment of Brain Tumors in the Alberta Cancer Registry, 2010-2015.
Eckstrand A; Shack L; Pham TM; Davis F
J Registry Manag; 2018; 45(3):109-116. PubMed ID: 31017880
[TBL] [Abstract][Full Text] [Related]
46. Towards optimal clinical and epidemiological registration of haematological malignancies: Guidelines for recording progressions, transformations and multiple diagnoses.
Gavin A; Rous B; Marcos-Gragera R; Middleton R; Steliarova-Foucher E; Maynadie M; Zanetti R; Visser O;
Eur J Cancer; 2015 Jun; 51(9):1109-22. PubMed ID: 24630945
[TBL] [Abstract][Full Text] [Related]
47. Ascertainment of breast cancer by the Scottish Cancer Registry: an assessment based on comparison with five independent breast cancer trials databases.
Brewster DH; Stockton DL
Breast; 2008 Feb; 17(1):104-6. PubMed ID: 17855094
[TBL] [Abstract][Full Text] [Related]
48. Reliability of cancer registration data in Scotland, 1997.
Brewster DH; Stockton D; Harvey J; Mackay M
Eur J Cancer; 2002 Feb; 38(3):414-7. PubMed ID: 11818208
[TBL] [Abstract][Full Text] [Related]
49. Validity of cancer registry data for measuring the quality of breast cancer care.
Malin JL; Kahn KL; Adams J; Kwan L; Laouri M; Ganz PA
J Natl Cancer Inst; 2002 Jun; 94(11):835-44. PubMed ID: 12048271
[TBL] [Abstract][Full Text] [Related]
50. Ascertainment and accuracy of Down syndrome cases reported in congenital anomaly registers in England and Wales.
Savva GM; Morris JK
Arch Dis Child Fetal Neonatal Ed; 2009 Jan; 94(1):F23-7. PubMed ID: 18375610
[TBL] [Abstract][Full Text] [Related]
51. Data quality at the Icelandic Cancer Registry: comparability, validity, timeliness and completeness.
Sigurdardottir LG; Jonasson JG; Stefansdottir S; Jonsdottir A; Olafsdottir GH; Olafsdottir EJ; Tryggvadottir L
Acta Oncol; 2012 Sep; 51(7):880-9. PubMed ID: 22974093
[TBL] [Abstract][Full Text] [Related]
52. The NCI All Ireland Cancer Conference.
Johnston PG; Daly PA; Liu E
Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
[TBL] [Abstract][Full Text] [Related]
53. Incidence of haematological malignancies by ethnic group in England, 2001-7.
Shirley MH; Sayeed S; Barnes I; Finlayson A; Ali R
Br J Haematol; 2013 Nov; 163(4):465-77. PubMed ID: 24033296
[TBL] [Abstract][Full Text] [Related]
54. Validation of congenital anomaly coding in Canada's administrative databases compared with a congenital anomaly registry.
Metcalfe A; Sibbald B; Lowry RB; Tough S; Bernier FP
Birth Defects Res A Clin Mol Teratol; 2014 Feb; 100(2):59-66. PubMed ID: 24307632
[TBL] [Abstract][Full Text] [Related]
55. Cerebral palsy registers and high-quality data: an evaluation of completeness of the 4Child register using capture-recapture techniques.
Surman G; da Silva AA; Kurinczuk JJ
Child Care Health Dev; 2012 Jan; 38(1):98-107. PubMed ID: 21752062
[TBL] [Abstract][Full Text] [Related]
56. Quality, comparability and methods of analysis of data on childhood cancer in Europe (1978-1997): report from the Automated Childhood Cancer Information System project.
Steliarova-Foucher E; Kaatsch P; Lacour B; Pompe-Kirn V; Eser S; Miranda A; Danzon A; Ratiu A; Parkin DM
Eur J Cancer; 2006 Sep; 42(13):1915-51. PubMed ID: 16919762
[TBL] [Abstract][Full Text] [Related]
57. Is the Quebec provincial administrative database a valid source for research on chronic non-cancer pain?
Lacasse A; Ware MA; Dorais M; Lanctôt H; Choinière M
Pharmacoepidemiol Drug Saf; 2015 Sep; 24(9):980-90. PubMed ID: 26105572
[TBL] [Abstract][Full Text] [Related]
58. Data quality at the Bulgarian National Cancer Registry: An overview of comparability, completeness, validity and timeliness.
Dimitrova N; Parkin DM
Cancer Epidemiol; 2015 Jun; 39(3):405-13. PubMed ID: 25914137
[TBL] [Abstract][Full Text] [Related]
59. Limitations of using a cancer registry to identify incident primary intracranial tumours.
Counsell CE; Collie DA; Grant R
J Neurol Neurosurg Psychiatry; 1997 Jul; 63(1):94-7. PubMed ID: 9221974
[TBL] [Abstract][Full Text] [Related]
60. An Innovative Approach to Improve Completeness of Treatment and Other Key Data Elements in a Population-Based Cancer Registry: A15-Month Data Submission.
Hsieh MC; Mumphrey B; Pareti L; Yi Y; Wu XC
J Registry Manag; 2017; 44(2):69-75. PubMed ID: 29611688
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
